Chison Medical Technologies Co., Ltd. (SHA:688358)

SHA:688358 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	140.51	146.48	105.84	112.47
Depreciation & Amortization	14.32	14.26	13.03	9.89
Other Amortization	0.71	0.04	0.13	0.24
Loss (Gain) From Sale of Assets	-4.61	-3.02	0.5	-30.25
Asset Writedown & Restructuring Costs	-	0.06	0.51	1.58
Loss (Gain) From Sale of Investments	-6.29	-11.17	-15	-17.53
Provision & Write-off of Bad Debts	1.7	3.58	-1.4	0.74
Other Operating Activities	-16.92	-19.06	-15.19	6.22
Change in Accounts Receivable	-1.01	-78.87	37.02	-1.55
Change in Inventory	5.65	56.08	-100.41	-16.76
Change in Accounts Payable	7.83	-20.33	41.92	-25.33
Change in Other Net Operating Assets	-2.03	-2.92	-0.82	1.37
Operating Cash Flow	140.68	85.91	63.74	39.96
Operating Cash Flow Growth	63.76%	34.78%	59.51%	-51.53%
Capital Expenditures	-8.85	-34.01	-52.21	-39.19
Sale of Property, Plant & Equipment	5.01	3.71	0.09	21.17
Investment in Securities	535.7	-236.03	-	165
Other Investing Activities	23.68	25.15	6.69	17.1
Investing Cash Flow	555.53	-241.18	-45.43	164.09
Long-Term Debt Repaid	-4.3	-0.95	-0.93	-0.61
Net Debt Issued (Repaid)	-4.3	-0.95	-0.93	-0.61
Issuance of Common Stock	-	-	2.02	-
Repurchase of Common Stock	-	-10.1	-	-
Common Dividends Paid	-89.5	-78.49	-40	-64
Financing Cash Flow	-93.8	-89.53	-38.91	-64.61
Foreign Exchange Rate Adjustments	12.24	9.34	21.59	-2.99
Net Cash Flow	614.64	-235.47	0.99	136.45
Free Cash Flow	131.83	51.9	11.53	0.78
Free Cash Flow Growth	154.02%	350.04%	1386.91%	-98.50%
Free Cash Flow Margin	28.13%	10.73%	3.03%	0.19%
Free Cash Flow Per Share	1.18	0.47	0.10	0.01
Cash Income Tax Paid	-2.42	0.48	-6.43	-14.31
Levered Free Cash Flow	103.64	-2.85	-16.31	5.74
Unlevered Free Cash Flow	103.87	-2.63	-16.24	5.78
Change in Working Capital	11.26	-45.26	-24.68	-43.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.